Published in Law and Health Weekly, September 5th, 2009
Watson intends to use the net proceeds from the offering to fund a portion of the cash consideration for Watson's previously announced acquisition of the privately-held Arrow Group, to redeem the $575 million aggregate principal amount outstanding of its contingent senior debentures due 2023 and to repay $100 million of term loan borrowings under its existing credit agreement. The senior unsecured offering is not conditioned on the completion...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Law and Health Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.